Home › Funds › Two Sigma Investments › TRVI
Two Sigma Investments position in TRVI
TREVI THERAPEUTICS INC · Health Care
Latest position (Q1 2026)38.41K sh
Reported value held$458.29K
Portfolio Weight0.00%
First reportedQ3 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 79.44K | $122.00K | New |
| Q4 2022 | 28.65K | $55.30K | Reduce |
| Q1 2023 | 12.93K | $23.92K | Reduce |
| Q4 2024 | 135.81K | $559.52K | New |
| Q1 2025 | 117.74K | $740.56K | Reduce |
| Q1 2025 | 117.74K | $740.56K | Reduce |
| Q2 2025 | 120.24K | $657.71K | Add |
| Q2 2025 | 120.24K | $657.71K | Add |
| Q3 2025 | 119.93K | $1.10M | Hold |
| Q4 2025 | 83.75K | $1.05M | Reduce |
| Q1 2026 | 38.41K | $458.29K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TRVI
- Fidelity Management & Research (FMR) 12.56M sh · $234.30M · Q2 2026
- BlackRock Inc 11.16M sh · $208.04M · Q2 2026
- Wellington Management Group 5.68M sh · $106.02M · Q2 2026
- Vanguard Group 6.43M sh · $80.56M · Q4 2025
- Geode Capital Management 2.93M sh · $54.62M · Q2 2026
- Marshall Wace 2.67M sh · $49.87M · Q2 2026
- Viking Global Investors 1.54M sh · $28.81M · Q2 2026
- Bank of America Corp 1.53M sh · $28.59M · Q2 2026
- Goldman Sachs Group 1.20M sh · $22.43M · Q2 2026
- Northern Trust Corp 1.01M sh · $18.76M · Q2 2026
- Charles Schwab Investment Management 965.40K sh · $18.00M · Q2 2026
- Balyasny Asset Management 845.09K sh · $15.76M · Q2 2026